) on thoracic duct embolization (TDE) for nonmixed GGO lesions (80%). 5 Moreover, the sensitivity is lower for smaller lesions (35%-67% for those Յ 10 mm) than larger lesions. 4 , 5 False-negative rates were reported to be about 20% to 30%. 3 , 5 The rate of concordance between core needle and surgical biopsies in malignant and premalignant lesions was only 73%, and core biopsy failed to identify the area of invasion. 3 We recommend that persistent pure GGO lesions Ն 10 mm be surgically resected for histologic examination and treatment, based on the high probability (42.9%) of growth during follow-up in our study, 1 although there remains the possibility of overdiagnosis in a portion of the patients who undergo surgery. For pure GGO lesions measuring , 10 mm, a strategy of long-term follow-up and selective surgery for growing lesions seems reasonable considering the low probability of growth. However, we agree that CT scanguided biopsy could be considered in pure GGOs of Ն 10 mm for which surgery is contraindicated or in patients who refuse surgery. It is evident that TDE will soon defi nitively replace surgical thoracic duct ligation (TDL) because morbidity is signifi cantly reduced by using this technique. To better understand the benefi ts of this procedure, we need information about the routes of chyle recanalization after thoracic duct occlusion. Apparently, postoperative recurrent chylothorax or proximal chylous effusions are signifi cantly reduced in patients undergoing TDE compared with those treated with TDL. This complication is common in patients with generalized lymphatic anomalies undergoing TDL. Are lymphatic-venous communications more easily opened and better functioning after TDE?
traumatic chylous effusion. The authors are to be applauded for approaching a diffi cult topic with poorly established standards and a high mortality rate. This is an important condition for chest physicians to understand and manage. Unfortunately, and despite the authors' vast experience in the management of . 160 patients with this frequently devastating disorder, the etiology of spontaneous or idiopathic chylothorax remains unexplained. What are the mechanisms for the thoracic duct undergoing obstruction in patients with no previous disease and normal MRI thoracic examinations? Up to 20% of patients with nontraumatic chylous effusions present with lymphatic anomalies (lymphatic malformations, generalized lymphatic disease [lymphangiomatosis], or Gorham-Stout disease). 2 Children with massive lymphatic malformations in the neck, axilla, or groin do not develop lymphatic duct obstruction with lymphedema. We do not have information regarding compared outcomes of TDE in patients with or without associated lymphatic malformations.
It is evident that TDE will soon defi nitively replace surgical thoracic duct ligation (TDL) because morbidity is signifi cantly reduced by using this technique. To better understand the benefi ts of this procedure, we need information about the routes of chyle recanalization after thoracic duct occlusion. Apparently, postoperative recurrent chylothorax or proximal chylous effusions are signifi cantly reduced in patients undergoing TDE compared with those treated with TDL. This complication is common in patients with generalized lymphatic anomalies undergoing TDL. Are lymphatic-venous communications more easily opened and better functioning after TDE?
Nontraumatic chylothorax in children aged , 10 years remains an unsolved problem. Because successful TDE has been reported in the treatment of post-cardiac surgery chylothorax in small children, 3 there are optimistic expectations of TDE improving the mortality rate in the pediatric population affected by pulmonary or disseminated lymphangiomatosis. 4 We encourage pediatric interventional radiologists and thoracic surgeons involved in the management of children with chylothorax in the context of life-threatening lymphatic anomalies to develop and promote noninvasive techniques in the management of these patients.
journal.publications.chestnet.org 
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To the Editor:
We thank Dr López-Gutiérrez for his interest in our recent work in CHEST . 1 The etiology of idiopathic chylothorax has indeed been hardly investigated and in most parts remains unsolved. We suggest that all cases of idiopathic chylothorax can be divided into two major categories: (1) occlusion of the upper part of the thoracic duct (TD) with development of compensatory collaterals and (2) chylous leak in the presence of a lymphatic malformation.
We believe that the cause of TD occlusion is subclinical trauma. In these cases, multiple lymphatic collaterals develop as a new route to the venous system. If one of these collaterals abut a serous surface (pleural, pericardial, or peritoneal), it can rupture and then result in a chylous leak. 2 Traditional lymphangiogram can easily diagnose TD occlusion.
MRI ductography, 3 which uses noncontrast fl uid-weighted MRI sequences, allows visualization of not only the TD but also other abnormal lymphatic structures such as congenital lymphatic malformations. We hypothesize that an unidentifi ed insult can result in a rupture of these structures and leakage of the chyli. If a leak from these structures happens proximal to the cisterna chyli, TD embolization (TDE) can be devastating, diverting all the fl ow from the TD into the leak.
Over the years, we have developed an algorithm to diagnose and treat idiopathic chylous effusions. We fi rst perform magnetic resonance ductogram to identify TD and other lymphatic structures/malformations. Then, we perform conventional or intranodal lymphangiography. 4 In cases of occlusion of the upper portion of the TD or demonstration of the leak, TDE usually cures chylothorax. In cases where TD is patent and the fl ow is normal, TDE should be avoided. Occasionally, oily-based contrast introduced during lymphangiogram can facilitate closure of the leak. 5 More distal occlusion of the TD leaves a longer segment of the TD intact, creating more opportunities for development of new lymphovenous anastomosis. The advantage of the TDE vs thoracic duct ligation is the ability to visualize the leak and occlude TD close to the leak age point (comparing to proximal supradiaphragmatic ligation of the TD in thoracic duct ligation). This potentially can result in development of more lymphovenous communications after TDE and reduction of the chylothorax recurrence.
Finally, future development of new imaging lymphatic agents may provide us with deeper insight into anatomy, physiology, and fl ow dynamics in the lymphatic system. Hopefully, these new insights will trigger further research and understanding of this vital yet overlooked "human plumbing" system. 
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